← BIOGEN INC. BIIB
Market Price
$209.75
Market Cap
$31.11B
P/E Ratio
23.86
Revenue (FY 2025)
↑2.2% YoY
$9.89B
3-Yr CAGR: -0.9%
Net Income
↓-20.8% YoY
$1.29B
Net Margin: 13.1%
Free Cash Flow
↓-24.7% YoY
$2.05B
FCF Yield: 6.59%
EPS (Diluted)
↓-21.4% YoY
$8.79
Basic: $8.83
Return on Equity
Efficiency
8.7%
ROA: 14.4%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (BIIB)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $11,448.8M | — | $9,970.1M | $3,702.8M | — | $16.93 | — | $4,522.4M | $3,906.3M | — |
| FY 2017 | $12,273.9M | +7.2% | $10,643.9M | $2,539.1M | -31.4% | $11.92 | -29.6% | $4,551.0M | $3,683.6M | -5.7% |
| FY 2018 | $13,452.9M | +9.6% | $11,636.6M | $4,430.7M | +74.5% | $21.58 | +81.0% | $6,187.7M | $5,417.1M | +47.1% |
| FY 2019 | $14,377.9M | +6.9% | $12,422.5M | $5,888.5M | +32.9% | $31.42 | +45.6% | $7,078.6M | $6,564.1M | +21.2% |
| FY 2020 | $13,444.6M | -6.5% | $11,639.4M | $4,000.6M | -32.1% | $24.80 | -21.1% | $4,229.8M | $3,805.0M | -42.0% |
| FY 2021 | $10,981.7M | -18.3% | $8,872.0M | $1,556.1M | -61.1% | $10.40 | -58.1% | $3,639.9M | $3,381.8M | -11.1% |
| FY 2022 | $10,173.4M | -7.4% | $7,895.1M | $3,046.9M | +95.8% | $20.87 | +100.7% | $1,384.3M | $1,144.0M | -66.2% |
| FY 2023 | $9,835.6M | -3.3% | $7,302.2M | $1,161.1M | -61.9% | $7.97 | -61.8% | $1,547.2M | $1,270.2M | +11.0% |
| FY 2024 | $9,675.9M | -1.6% | $7,365.5M | $1,632.2M | +40.6% | $11.18 | +40.3% | $2,875.5M | $2,721.8M | +114.3% |
| FY 2025 | $9,890.6M | +2.2% | $7,486.4M | $1,292.9M | -20.8% | $8.79 | -21.4% | $2,204.6M | $2,050.8M | -24.7% |
Valuation
Market Price
$209.75
Market Cap
$31.11B
Enterprise Value
$34.48B
P/E Ratio
23.86
P/B Ratio
2.09
FCF Yield
6.59%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
75.69%
Operating Margin
0.25%
Net Margin
13.07%
Return on Equity (ROE)
8.74%
Return on Assets (ROA)
14.41%
Asset Turnover
1.10x
Revenue 3-Yr CAGR
-0.94%
Financial Health & Liquidity
Current Ratio
2.68
Cash Ratio
0.87
Debt / Equity
0.425
Debt / Assets
0.701
Cash & Equivalents
$2.91B
Total Debt
$6.29B
Book Value / Share
$100.24
Cash Flow Efficiency
Operating Cash Flow
$2.20B
Capital Expenditures (CapEx)
$153.80M
Free Cash Flow
$2.05B
OCF / Revenue
22.29%
FCF / Revenue
20.73%
FCF 3-Yr CAGR
21.48%
Per Share Metrics
EPS (Diluted)
$8.79
EPS (Basic)
$8.83
Dividends / Share
N/A
Book Value / Share
$100.24
EPS YoY Growth
-21.38%
Balance Sheet (FY 2025)
Total Assets
$8.97B
Total Liabilities
$3.35B
Stockholders' Equity
$14.80B
Current Assets
$8.97B
Current Liabilities
$3.35B